The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer. More than one in three people will develop cancer in their lifetime2 ...

Hims and Hers Health has acquired at-home lab testing facility Trybe Labs. The company separately announced it has acquired a U.S.-based peptide facility in California. The startup is expanding its ...

The acquisition will unlock a new level of personalized healthcare and deliver integrated offerings across nutrition, lifestyle, supplements, and medication SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers ...

Direct-to-consumer virtual care company Hims & Hers has acquired at-home lab testing facility Sigmund NJ LLC, also known as Trybe Labs. Hims & Hers said the acquisition of the New Jersey-based testing ...

Hims & Hers, a leading telehealth platform, announced today that it plans to introduce at-home testing for its customers after acquiring a new lab. The company acquired Trybe Labs, an at-home testing ...

Hims & Hers Health is offering lab testing, part of the telehealth platform’s growing focus on preventive care. The company expects the new offering to add to its user base as it draws customers ...

Hims & Hers said it will offer access to Galleri, a blood-based multi-cancer early detection test from GRAIL Inc. that screens for signals associated with more than 50 types of cancer, including ...

Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...

The ad, which aired during the Super Bowl over the weekend, promoted a new product by Hims & Hers, a blood test designed to detect over 50 types of cancer before symptoms appear. This includes hard-to ...